Early-Stage Treatment with Withaferin A Reduces Levels of Misfolded Superoxide Dismutase 1 and Extends Lifespan in a Mouse Model of Amyotrophic Lateral Sclerosis

Title
Early-Stage Treatment with Withaferin A Reduces Levels of Misfolded Superoxide Dismutase 1 and Extends Lifespan in a Mouse Model of Amyotrophic Lateral Sclerosis
Authors
Keywords
ALS, Neuroinflammation, Withaferin A, SOD1<sup>G93A</sup>, SOD1<sup>G37R</sup>
Journal
Neurotherapeutics
Volume 12, Issue 1, Pages 217-233
Publisher
Springer Nature
Online
2014-11-22
DOI
10.1007/s13311-014-0311-0

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started